“We are making significant progress to ensure the long-term success of the business as we continue on our mission,” said Anne Wojcicki, CEO and Co-Founder of 23andMe. “We have been focused on growing ...

23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The embattled genetics company said Monday that it's cutting about 200 jobs, or about 40% ...

One of the most popularly-recognized biotechnology companies, 23andMe, has filed for bankruptcy. Before the company sells it assets, users are able to download and delete their data, if they wish.

SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and ...

SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ ...

23andMe on Tuesday reported declining revenue in its most recent quarter, a day after the company said it will cut 40% of its workforce and shutter its therapeutics business as part of a business ...

Balance Sheet and Liquidity23andMe ended December 31, 2024 with cash and cash equivalents of $79.4 million, compared to $126.6 million as of September 30, 2024 and $216.5 million as of March 31, 2024.